Diagnostics News and Research

RSS

AdMeTech Foundation: Health care reform highlights need for better screening and prevention of prostate cancer

AdMeTech Foundation announced today that its President and CEO Dr. Faina Shtern will testify on March 4 before the U.S. House Committee on Oversight and Government Reform on how health care reform highlights the need for increased funding for research aimed at creating accurate, life-saving diagnostic tools for prostate cancer, which will improve screening, prevention, early detection and reduce health costs.

2 Mar 2010

Precise immune disturbances leading to Coeliac disease: More insight

New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified. These latest findings could speed the way towards improved diagnostics and treatments for the autoimmune complaint that affects 1 in 100 of the population, and lead to insights into related conditions such as type 1 diabetes.

28 Feb 2010

MDB Capital Group selects Health Discovery as one of Top 50 “Best and Brightest” companies

Health Discovery Corporation announced today it has been selected by MDB Capital Group as one of its Top 50 “Best and Brightest” companies that will present at the invitation-only, 1st Annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property.

27 Feb 2010

Cotton thread as core material in 'lab-on-chip' devices to detect kidney failure and diabetes

A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost 'lab-on-chip' devices capable of detecting diseases such as kidney failure and diabetes.

27 Feb 2010

Phadia AB plans to provide access for specialists to peanut allergen components

Today, at the 2010 Annual Meeting of The American Academy of Allergy, Asthma & Immunology (AAAAI) Phadia, the world leader in in vitro allergy diagnostics, announced plans to provide access for specialists to peanut allergen components. These plans support Phadia’s goal to expand collaboration with allergy and immunology specialists in order to advance the understanding of the clinical utility of allergen component test results.

27 Feb 2010

CAMH signs licensing agreement with US-based Athena Diagnostics to market new genetic test

For the second time in as many months the Centre for Addiction and Mental Health has signed a licensing agreement with US-based Athena Diagnostics Inc. to market a new genetic test.

From Thermo Fisher Scientific Inc. 26 Feb 2010

Genoptix to participate in Aetna's national provider network to offer laboratory and diagnostic services

Genoptix, Inc. today announced that it will participate in Aetna's (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.

26 Feb 2010

Rapid, multiplexed genotyping method to identify SNPs that affect warfarin dose developed

Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al, "Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry," appears in the March 2010 issue of the Journal of Molecular Diagnostics.

26 Feb 2010

Study: Relentless progression of new, expensive medical technology have created perfect storm of costs

Emerging Healthcare Solutions, Inc. reflected on a new Henry J. Kaiser Family Foundation www.kff.org study that reports that the relentless progression of new and expensive medical technology, combined with entitlement programs like Medicare and Medicaid, further compounded by an aging population, have created a "perfect storm" of costs that will consume well over half of all federal spending between now and the turn of the mid-century.

26 Feb 2010

Helicos BioSciences to demonstrate single molecule sequencing using Helicos Genetic Analysis System

Helicos BioSciences and it’s collaborators will deliver presentations featured at the Advances in Genome Biology and Technology (AGBT) meeting in Marco Island, Florida, from February 24-27, 2010.

26 Feb 2010

NeoGenomics' fourth-quarter revenue up 32%

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter 2009 and fiscal year ended December 31, 2009.

25 Feb 2010

Study examines how individuals utilize benefits and services under Medicare program

Findings released today and detailed in the analysis Low Consumption and Higher Medicare Cost: Consumption Clusters in a Medicare Fee-for-Service Population, examine how individuals utilize benefits and services under the Medicare program.

25 Feb 2010

Asymptomatic pancreatic cyst treatment: UCLA-Veterans Affairs research team develops evaluation tool

As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient's lifetime.

25 Feb 2010

JVC offers treatment for vascular diseases and thrombotic disorders under one roof

The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.

25 Feb 2010

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

25 Feb 2010

Unique technology identifies drug candidates, speeds up drug development

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate.

From NanoTemper Technologies 24 Feb 2010

New report identifies enormous global impact of preterm birth and stillbirth

A new report issued today identifies the enormous global impact of preterm birth and stillbirth-and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000.

24 Feb 2010

Research addresses preterm birth, stillbirth health issues, highlights preventive interventions

New research published in BMC Pregnancy and Childbirth notes some of the "serious short- and long-term health issues" associated with preterm births and identifies steps that can be taken to reduce the number of stillbirths and premature births worldwide, United Press International reports.

24 Feb 2010

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, has joined the Personalized Medicine Coalition, an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, defined as the application of genomic and molecular data to better target the delivery of healthcare by determining a person's predisposition to a particular disease or condition.

24 Feb 2010

Alliance Biosciences to provide engineering and biosafety guidance for Nyumbani's HIV/TB diagnostic facility

Alliance Biosciences reached an agreement with the Nyumbani Children's Home in Kenya to provide engineering and biosafety guidance to Nyumbani's planned HIV/TB diagnostic facility.

24 Feb 2010

Diagnostics News and Research

AdMeTech Foundation: Health care reform highlights need for better screening and prevention of prostate cancer

Precise immune disturbances leading to Coeliac disease: More insight

MDB Capital Group selects Health Discovery as one of Top 50 “Best and Brightest” companies

Cotton thread as core material in 'lab-on-chip' devices to detect kidney failure and diabetes

Phadia AB plans to provide access for specialists to peanut allergen components

CAMH signs licensing agreement with US-based Athena Diagnostics to market new genetic test

Genoptix to participate in Aetna's national provider network to offer laboratory and diagnostic services

Rapid, multiplexed genotyping method to identify SNPs that affect warfarin dose developed

Study: Relentless progression of new, expensive medical technology have created perfect storm of costs

Helicos BioSciences to demonstrate single molecule sequencing using Helicos Genetic Analysis System

NeoGenomics' fourth-quarter revenue up 32%

Study examines how individuals utilize benefits and services under Medicare program

Asymptomatic pancreatic cyst treatment: UCLA-Veterans Affairs research team develops evaluation tool

JVC offers treatment for vascular diseases and thrombotic disorders under one roof

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

Unique technology identifies drug candidates, speeds up drug development

New report identifies enormous global impact of preterm birth and stillbirth

Research addresses preterm birth, stillbirth health issues, highlights preventive interventions

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

Alliance Biosciences to provide engineering and biosafety guidance for Nyumbani's HIV/TB diagnostic facility

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News